Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$80.52 - $93.75 $37,763 - $43,968
-469 Reduced 12.68%
3,229 $274,000
Q1 2022

May 10, 2022

BUY
$80.11 - $90.62 $296,246 - $335,112
3,698 New
3,698 $324,000
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $198,692 - $219,708
-2,493 Closed
0 $0
Q2 2021

Aug 09, 2021

BUY
$85.24 - $94.15 $212,503 - $234,715
2,493 New
2,493 $228,000
Q3 2019

Nov 08, 2019

SELL
$85.54 - $94.26 $434,201 - $478,463
-5,076 Closed
0 $0
Q2 2019

Aug 06, 2019

BUY
$75.4 - $92.8 $8,369 - $10,300
111 Added 2.24%
5,076 $461,000
Q1 2019

May 10, 2019

BUY
$75.32 - $86.15 $63,871 - $73,055
848 Added 20.6%
4,965 $475,000
Q4 2018

Feb 15, 2019

BUY
$73.66 - $82.02 $303,258 - $337,676
4,117 New
4,117 $352,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Western Wealth Management, LLC Portfolio

Follow Western Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Western Wealth Management, LLC with notifications on news.